EA201691270A1 - Усовершенствованные составы, содержащие виросомы - Google Patents

Усовершенствованные составы, содержащие виросомы

Info

Publication number
EA201691270A1
EA201691270A1 EA201691270A EA201691270A EA201691270A1 EA 201691270 A1 EA201691270 A1 EA 201691270A1 EA 201691270 A EA201691270 A EA 201691270A EA 201691270 A EA201691270 A EA 201691270A EA 201691270 A1 EA201691270 A1 EA 201691270A1
Authority
EA
Eurasian Patent Office
Prior art keywords
virosomes
compositions containing
improved compositions
composition
containing virosomes
Prior art date
Application number
EA201691270A
Other languages
English (en)
Other versions
EA030733B1 (ru
Inventor
Яник Адриансен
Франческо Доро
Original Assignee
Круселл Холланд Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Круселл Холланд Б.В. filed Critical Круселл Холланд Б.В.
Publication of EA201691270A1 publication Critical patent/EA201691270A1/ru
Publication of EA030733B1 publication Critical patent/EA030733B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5184—Virus capsids or envelopes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В настоящем изобретении представлены составы на основе виросом, в частности жидкие фармацевтические составы, содержащие виросомы. Предпочтительный вариант осуществления представляет собой композицию, содержащую а) виросомы; b) KHPO/NaHPOбуфер, где концентрация фосфата изменяется в пределах от примерно 15 до 30 мМ; с) соль, где концентрация соли выше чем 60 мМ; d) дисахарид, где указанная композиция имеет рН, значение которого находится в интервале от 6,5 до 8. Также раскрывается способ сохранения виросом путем приготовления описанной выше композиции.
EA201691270A 2013-12-19 2014-12-18 Жидкая композиция для сохранения виросом и способ сохранения виросом EA030733B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13198296 2013-12-19
PCT/EP2014/078463 WO2015091798A2 (en) 2013-12-19 2014-12-18 Improved formulations for virosomes

Publications (2)

Publication Number Publication Date
EA201691270A1 true EA201691270A1 (ru) 2016-12-30
EA030733B1 EA030733B1 (ru) 2018-09-28

Family

ID=49880456

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691270A EA030733B1 (ru) 2013-12-19 2014-12-18 Жидкая композиция для сохранения виросом и способ сохранения виросом

Country Status (11)

Country Link
US (2) US20160317646A1 (ru)
EP (1) EP3082769B1 (ru)
JP (1) JP6469698B2 (ru)
KR (1) KR102391228B1 (ru)
CN (1) CN105899220B (ru)
AU (1) AU2014368594B2 (ru)
BR (1) BR112016013920B1 (ru)
CA (1) CA2934434C (ru)
EA (1) EA030733B1 (ru)
SG (1) SG11201604136PA (ru)
WO (1) WO2015091798A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11523988B2 (en) 2018-11-29 2022-12-13 Catalent U.K. Swindon Zydis Limited Oral dispersible vaccine comprising virosomes

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148876A (en) * 1975-09-29 1979-04-10 Burroughs Wellcome Co. Biological preparations
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
JPH07121871B2 (ja) * 1986-10-09 1995-12-25 国立予防衛生研究所長 インフルエンザワクチン凍結乾燥製剤
US7253262B2 (en) * 1995-01-19 2007-08-07 Quandrant Drug Delivery Limited Dried blood factor composition comprising trehalose
GB9501040D0 (en) * 1995-01-19 1995-03-08 Quadrant Holdings Cambridge Dried composition
WO2001066137A1 (en) * 2000-03-07 2001-09-13 Merck & Co., Inc. Adenovirus formulations
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US20040028687A1 (en) * 2002-01-15 2004-02-12 Waelti Ernst Rudolf Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
MXPA05004528A (es) * 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
CA2506593C (en) * 2002-11-21 2012-02-07 Pevion Biotech Ltd. High-efficiency fusogenic vesicles, methods of producing them, and pharmaceutical compositions containing them
EP1676569A1 (en) * 2004-12-30 2006-07-05 Pevion Biotech Ltd. Lyophilization of virosomes
WO2011090712A2 (en) * 2009-12-28 2011-07-28 Ligocyte Pharmaceuticals, Inc. Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
CN103228293A (zh) * 2010-11-30 2013-07-31 巴拉特生物技术国际有限公司 用于在哺乳动物中预防和治疗金迪普拉病毒感染的疫苗制剂

Also Published As

Publication number Publication date
BR112016013920A2 (ru) 2017-08-08
CA2934434C (en) 2022-05-24
US20160317646A1 (en) 2016-11-03
US20200360510A1 (en) 2020-11-19
SG11201604136PA (en) 2016-07-28
BR112016013920B1 (pt) 2023-02-07
CN105899220A (zh) 2016-08-24
AU2014368594A1 (en) 2016-06-16
JP6469698B2 (ja) 2019-02-13
KR20160098452A (ko) 2016-08-18
CA2934434A1 (en) 2015-06-25
EP3082769A2 (en) 2016-10-26
WO2015091798A2 (en) 2015-06-25
EP3082769B1 (en) 2018-01-31
WO2015091798A3 (en) 2015-08-27
EA030733B1 (ru) 2018-09-28
KR102391228B1 (ko) 2022-04-28
JP2017502012A (ja) 2017-01-19
AU2014368594B2 (en) 2020-03-05
CN105899220B (zh) 2020-01-10

Similar Documents

Publication Publication Date Title
CO2018012181A2 (es) Compuestos arilo o heteroarilo sustituidos con amino como inhibidores de ehmt1 y ehmt2
EA201792354A1 (ru) Композиции обетихолевой кислоты и способы применения
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
MX2018015892A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
MX2019001253A (es) Conjugados de proteina-agente activo y metodo para su preparacion.
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
EA201791717A1 (ru) Стабильные водные составы адалимумаба
EA201891438A1 (ru) Кислотно-аддитивные соли производных пиперазина
EA201490815A1 (ru) Составы этанерцепта, стабилизированные с помощью аминокислот
EA201790722A1 (ru) КОМПОЗИЦИЯ С НИЗКИМ pH, СОДЕРЖАЩАЯ КОНКРЕТНЫЕ КОНСЕРВАЦИОННЫЕ СИСТЕМЫ
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
BR112015030011A2 (pt) composições e métodos para intensificar a germinação
MX2018001006A (es) Composicion farmaceutica que comprende un vector adenoviral.
EA201790672A1 (ru) Композиция, содержащая соль ацилглутамата в качестве основного поверхностно-активного вещества или основного анионного поверхностно-активного вещества
EA201400903A1 (ru) Композиции глины
EA201890771A1 (ru) Соли и твердые формы монобактамного антибиотика
TR201908247T4 (tr) Sodyum glikoz birlikte taşıyıcı 1 inhibitörleri.
EA201792689A1 (ru) Производные 2-(пиразолопиридин-3-ил)пиримидина в качестве ингибиторов jak
EA201691881A1 (ru) Новые соединения
EA201791896A1 (ru) Дезацетокситубулизин н и его аналоги
EA201391488A1 (ru) Композиции со сниженной вязкостью
EA201691363A1 (ru) Стабилизированные силикатные композиции и их применение в качестве антиперспирантных композиций
EA201790570A1 (ru) Модуляторы р2х7
EA201590041A1 (ru) Твердая форма холиновой соли вемурафениба
EA201890638A1 (ru) Отклоняющие кислоты, содержащие водорастворимое замедляющее действие средство, а также способы изготовления и применения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG TJ TM